These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 4071712)

  • 1. [A central venous catheter of the Hickman type used in patients with hematological diseases].
    Worning AM; Petersen FB; Frimodt-Møller C; Hippe E
    Ugeskr Laeger; 1985 Aug; 147(35):2753-5. PubMed ID: 4071712
    [No Abstract]   [Full Text] [Related]  

  • 2. [Central venous access in patients with Broviac- and Hickman catheters].
    Rubinstein BE; Susgaard S
    Ugeskr Laeger; 1985 Aug; 147(35):2750-3. PubMed ID: 3934820
    [No Abstract]   [Full Text] [Related]  

  • 3. [A subcutaneously implantable catheter in hematologic malignancy--a comparison with a conventional central venous catheter].
    Engervall P; Björkholm M; Backman L; Spira J; Lindquist G; Wetterlöv C
    Lakartidningen; 1988 Sep; 85(36):2839-42. PubMed ID: 3059105
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hickman catheter for hyperalimentation and treatment of leukemia].
    Rubin M; Waizer A; Dintsman M
    Harefuah; 1982 Nov; 103(9):190-1. PubMed ID: 6820350
    [No Abstract]   [Full Text] [Related]  

  • 5. Externalized Groshong catheters and Hickman ports for central venous access in gynecologic oncology patients.
    Gleeson NC; Fiorica JV; Mark JE; Pinelli DM; Hoffman MS; Roberts WS; Cavanagh D
    Gynecol Oncol; 1993 Dec; 51(3):372-6. PubMed ID: 8112648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Percutaneous implantation technic for a permanent venous access system to the superior vena cava].
    Sterz H; Zitter F
    Wien Med Wochenschr; 1984 Apr; 134(7):171-2. PubMed ID: 6741157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Advantages and disadvantages in the use of central venous catheters in children with malignant diseases].
    Sporisević L; Hasanbegović E; Hadzihasanović E; Bajraktarević A; Khatib H; Hamamdzić M
    Med Arh; 1999; 53(3 Suppl 2):19-22. PubMed ID: 10758755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of Hickman line- and Port-a-Cath-associated complications in patients with solid tumours undergoing chemotherapy.
    Ng F; Mastoroudes H; Paul E; Davies N; Tibballs J; Hochhauser D; Mayer A; Begent R; Meyer T
    Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):551-6. PubMed ID: 17517500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Infectious and non-infectious complications of tunneled central catheters in hematologic patients].
    Albo López C; López Rodríguez D; Constenla Camba MI; Jimenéz Blanco A; Araujo LF; García-Medina J
    Sangre (Barc); 1999 Jun; 44(3):176-81. PubMed ID: 10481577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Hickman catheter.
    Cox E
    Nurs Mirror; 1985 Sep; 161(13):34-6. PubMed ID: 3850591
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of the Port-a-cath subcutaneous central venous catheter in patients with malignant blood diseases].
    la Cour Petersen E; Husegaard HC
    Ugeskr Laeger; 1986 Jun; 148(27):1672-5. PubMed ID: 3750449
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of Hickman catheters on the self-esteem of patients with leukemia.
    Newman KA; Schnaper N; Reed WP; deJongh CA; Schimpff SC
    South Med J; 1984 Jun; 77(6):682-5. PubMed ID: 6729541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies.
    Chee L; Brown M; Sasadeusz J; MacGregor L; Grigg AP
    J Infect; 2008 Apr; 56(4):227-33. PubMed ID: 18342947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New implantable systems in intensive long-term chemotherapy of leukemias and lymphomas].
    Agolini G; Lipartiti T; Milani A; Paparazzo R
    Recenti Prog Med; 1985 Jun; 76(6):316-8. PubMed ID: 4059627
    [No Abstract]   [Full Text] [Related]  

  • 15. Venous access ports: frequency and management of complications in oncology patients.
    Jordan K; Behlendorf T; Surov A; Kegel T; Maher G; Wolf HH
    Onkologie; 2008 Jul; 31(7):404-10. PubMed ID: 18596390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hickman catheters for chemotherapy in patients with acute myeloblastic leukemia].
    Hvid K; Rosenborg D
    Ugeskr Laeger; 2005 Nov; 167(48):4566-9. PubMed ID: 16324439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insertion of Hickman catheters by the percutaneous technique.
    Teh A; Leong KW
    Med J Malaysia; 1995 Dec; 50(4):353-8. PubMed ID: 8668056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long term central venous catheterization revisited].
    Palermo S; Campolucci A; Capozza F; Cammardella MP; Balestrero A; Ferrando F; Basta P; Launo C
    Minerva Anestesiol; 1995 Nov; 61(11):451-6. PubMed ID: 8677035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central venous catheterization in pediatric patients affected by hematological malignancies.
    Cogliati AA; Dell'Utri D; Picardi A; Testi AM; Micozzi A; Pasotti E; Rosa G
    Haematologica; 1995; 80(5):448-50. PubMed ID: 8566889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual lumen catheters for angioaccess in patients with leukemia.
    Reed WP; Newman KA; Schimpff SC; de Jongh CA; Wiernik PH
    Am Surg; 1983 Jul; 49(7):373-8. PubMed ID: 6614656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.